SSY Group Limited — Board/Management Information 2012

Mar 23, 2012

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [283 x 113] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2005)

FORMATION OF NOMINATION COMMITTEE

The Board announces that the Nomination Committee comprising Mr. Wang Yibing as chairman, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as members has been established by the Board with written terms of reference with effect from 23 March 2012.

The board (the “ Board ”) of directors (the “ Directors ”) of Lijun International Pharmaceutical (Holding) Co., Ltd. (the “ Company ”) announces that a nomination committee (the “ Nomination Committee ”) comprising Mr. Wang Yibing (“Mr. Wang”) as chairman, Mr. Leung Chong Shun (“Mr. Leung”) and Mr. Chow Kwok Wai (“Mr. Chow”) as members has been established by the Board with written terms of reference with effect from 23 March 2012. Mr. Wang, Mr. Leung and Mr. Chow are independent non-executive Directors.

The primary duties of the Nomination Committee include but not limited to the following:

• (1) review the structure, size and composition (including the skills, knowledge and experience) of the Board at least annually and make recommendations on any proposed changes to the Board to complement the Company’s corporate strategy;

1

• (2) identify individuals suitably qualified to become Board members and select or make recommendations to the Board on the selection of individuals nominated for directorships;

• (3) assess the independence of independent non-executive Directors; and

• (4) make recommendations to the Board on the appointment or re-appointment of Directors and succession planning for Directors, in particular the chairman and the chief executive officer.

By Order of the Board Chow Hing Yeung Company Secretary

Hong Kong, 23 March 2012

As at the date of this announcement, the Board comprises Mr. Wu Qin, Mr. Qu Jiguang, Mr. Xie Yunfeng, Mr. Huang Chao, Mr. Wang Xian Jun, Mr. Duan Wei, Ms. Zhang Guifu, Mr. Bao Leyuan and Ms. Gao Shuping as executive Directors, and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non-executive Directors.

2